Market Research Report
Global Implantable Cardioverter Defibrillators (ICD) Market 2018-2022
|Published by||TechNavio (Infiniti Research Ltd.)||Product code||759938|
|Published||Content info||114 Pages
Delivery time: 1-2 business days
|Global Implantable Cardioverter Defibrillators (ICD) Market 2018-2022|
|Published: December 12, 2018||Content info: 114 Pages||
Technological advances to drive growth in the market. Technological advances such as the introduction of quadripolar lead devices, improvements in patient monitoring to avoid needless shocks, and development of MRI safe ICDs have significantly improved the reliability and effectiveness of ICDs. Technavio's analysts have predicted that the implantable cardioverter defibrillators market will register a CAGR of almost 2% by 2022.
Prevalence of cardiac arrhythmias is steadily increasing. With the rise in cardiac disorders the demand for implantable cardioverter defibrillators will also increase.
ICDs have been associated with many undesirable effects such as lead failures, deterioration in the quality of life, repeated in appropriate shocks, and premature battery complications.
For the detailed list of factors that will drive and challenge the growth of the implantable cardioverter defibrillators market during the 2018-2022, view our report.
The market appears to be fragmented and with the presence of several companies including Abbott and BIOTRONIK the competitive environment is quite intense. Factors such as the technological advances and the increasing prevalence of cardiac arrhythmias, will provide considerable growth opportunities to implantable cardioverter defibrillators manufactures. Abbott, BIOTRONIK, Boston Scientific, and Medtronic are some of the major companies covered in this report.